Medical/Pharmaceuticals
Korea's Outstanding SMEs as Frontline Fighters against COVID-19
SEOUL, South Korea, April 12, 2021 /PRNewswire/ -- BSR Korea is encouraging and supporting decent and respectful domestic SMEs of prophylaxis industry to enter the global procurement-as-a-service market, as the government-entrusted organizing agency of the COVID-19 quarantine project, Marketing S...
2021-04-12 09:00
3731
Ascletis Announced Four Clinical and Preclinical Study Abstracts of NASH and HBV Accepted as Poster Presentations by the International Liver Congress™ 2021
HANGZHOU, China and SHAOXING, China, April 12, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) announces today that four clinical and preclinical study abstracts of NASH and HBV have been accepted by the International Liver Congress™ 2021 as poster presentations. The summary of the four abs...
2021-04-12 08:30
4490
Antengene Announces First Patient Dosed in Phase II Trial of ATG-008 (Onatasertib) in Patients with Advanced Solid Tumors with Specific Genetic Alterations
SHANGHAI and HONG KONG, April 12, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and onco...
2021-04-12 08:00
3607
Hummingbird Bioscience Presents Pre-Clinical Data on its Next-Generation BCMA-TACI Dual-Specific T Cell Engager at 2021 AACR Annual Meeting
SINGAPORE, April 10, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced that the company will be presentingpre-clinical data on its BCMA-TAC...
2021-04-10 12:01
4345
Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario
BRESCIA, Italy, April 10, 2021 /PRNewswire/ --
With an email to the main distributors, Copan group's CEO describes how the
ramp-up of Covid-19-related products has been concluded, and how the company is
now reorganizing to face post-pandemic challenges.
2021-04-10 01:43
5711
RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue
Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded safety data from the first 255 treated patients The 464-patient global Phase 2/3 COVID-19 study is ...
2021-04-09 19:00
5541
CDD Awarded $1.5M Phase 2 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization
BURLINGAME, Calif., April 9, 2021 /PRNewswire/ -- Collaborative Drug Discovery, provider ofCDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: "Intelligent Chemical Structure Browser for Drug Discovery...
2021-04-09 18:57
2051
Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
SHANGHAI, April 9, 2021 /PRNewswire/ -- Everest Medicines
2021-04-09 08:30
6693
Seegene supports Mexico's 'back to school' campaign with COVID-19 tests and face masks
SEOUL, South Korea, April 9, 2021 /PRNewswire/ -- South Korea's leading
molecular diagnostics firm Seegene Inc. (KQ096530) said Friday it is supporting
the Mexican government's push to return life to pre-pandemic days.
2021-04-09 04:08
2691
Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T
SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr.Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr...
2021-04-08 22:00
14440
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile
* Marks vaccine's first approval in South America, following Mexico, Pakistan, China and Hungary * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination TI...
2021-04-08 21:17
7677
Lunit will participate in a Groundbreaking Prospective Study to Validate AI Performance
* A research team at the Karolinska Institutet in Sweden will assess the performance of AI startup Lunit's breast cancer AI software as an independent mammography reader in screening * The prospective study marks first of its kind, aiming to screen 55,000 women with mammography at Capio Sankt...
2021-04-08 16:15
2474
SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software
BANGKOK, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickly ...
2021-04-08 15:00
2959
SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software
HONG KONG, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...
2021-04-08 15:00
3420
SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software
SINGAPORE, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...
2021-04-08 15:00
2715
SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software
KUALA LUMPUR, Malaysia, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solut...
2021-04-08 15:00
3273
EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt® In China
TEL-AVIV, Israel, April 8, 2021 /PRNewswire/ -- EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announces today that EndoArt® was granted the Innovative Device Status byChina's Center for Medical Device Evaluation, the ar...
2021-04-08 08:00
3032
Inmagene R&D Team expands with two new senior members joining the Company
SAN DIEGO and SHANGHAI and HANGZHOU, China, April 7, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced that Dr.Anbo Xiang and Dr.Qian Xu joined the company. As CMO (China) and Senior VP, Operations, Dr. Xiang will be responsible for clinical development, operations, an...
2021-04-07 09:00
18577
WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA
WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the U.S. FDA (FDA). T...
2021-04-07 08:22
23541
EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery
SHANGHAI and SUZHOU, China, April 7, 2021 /PRNewswire/ -- EDDA Healthcare and Technology Holding Ltd. and its subsidiaries EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc ( Princeton, NJ, USA), (hereafter jointly referred to as EDDA Techno...
2021-04-07 07:00
41735
Week's Top Stories
Most Reposted
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 328 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 310 media titles]
2026-02-26 19:57
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 309 media titles]
2026-02-26 09:30
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 302 media titles]
2026-02-24 16:13
Most Read
NYSE Content Update: AI Data Platform DDN Appoints Guido Torrini as Finance Chief
2026-02-24 22:08
5868
